Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Qianying Lv"'
Autor:
Ling Yang, Wanzhen Guan, Haimei Liu, Yifan Li, Yinv Gong, Qianying Lv, Qiaoqian Zeng, Qijiao Wei, Xiaomei Zhang, Weiming Chen, Chao Chen, Li Sun
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundJuvenile dermatomyositis (JDM) is a systemic autoimmune disease primarily involving the muscles and skin; it can also affect the central nervous system (CNS). The relevant literature provides limited information regarding the characteristic
Externí odkaz:
https://doaj.org/article/dab6206afe5542bc8cf884c242837d2f
Autor:
Qiaoqian Zeng, Haimei Liu, Guomin Li, Yifan Li, Wanzhen Guan, Tao Zhang, Yinv Gong, Xiaomei Zhang, Qianying Lv, Bingbing Wu, Hong Xu, Li Sun
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Background Blau syndrome is a rare autoinflammatory disease caused by autosomal dominant mutations in the CARD15/NOD2 gene. Vascular involvement is a rare phenotype in Blau syndrome patients. In this study, we aimed to describe a 20-year- ol
Externí odkaz:
https://doaj.org/article/467fe8894cfb40ebbbffd52ca5b6eff0
Autor:
Yinv Gong, Haimei Liu, Guomin Li, Tao Zhang, Yifan Li, Wanzhen Guan, Qiaoqian Zeng, Qianying Lv, Xiaomei Zhang, Wen Yao, Yu Shi, Hong Xu, Li Sun
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Objectives To characterize the clinical features and outcomes of childhood-onset primary Sjögren’s syndrome (pSS). Methods Patients less than 18 years old who were diagnosed with pSS by paediatric rheumatologists were included, and all pa
Externí odkaz:
https://doaj.org/article/29ecce081eb64207a75505dfebccc3f6
Autor:
Jiajia Ni, Sha Tian, Lin Bai, Qianying Lv, Jialu Liu, Jiaojiao Liu, Ye Fang, Yihui Zhai, Qian Shen, Jia Rao, Chen Ding, Hong Xu
Publikováno v:
BMC Pediatrics, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background In children, focal segmental glomerulosclerosis (FSGS) is the main cause of steroid resistant nephrotic syndrome (SRNS). To identify specific candidates and the mechanism of steroid resistance, we examined the formalin-fixed paraf
Externí odkaz:
https://doaj.org/article/a422fc634edc435c9f6394200e8e7e58
Autor:
Qianying Lv, Xinli Han, Jiajia Ni, Qianqian Ma, Rufeng Dai, Jiaojiao Liu, Jialu Liu, Yihui Zhai, Qian Shen, Li Sun, Haimei Liu, Jia Rao, Hong Xu
Publikováno v:
Cell Death and Disease, Vol 13, Iss 10, Pp 1-13 (2022)
Abstract Proteinuria, an indication of kidney disease, is caused by the malfunction of podocytes, which play a key role in maintaining glomerular filtration. Angiopoietin-like 3 (ANGPTL3) has been documented to have a cell-autonomous involvement in p
Externí odkaz:
https://doaj.org/article/a2045ac74e834b47aca94943747f40b9
Autor:
Fujie Wen, Junchao Liu, Rufeng Dai, Sha Hong, Baowei Ji, Jiaojiao Liu, Jun Zhang, Xinli Han, Qianying Lv, Jialu Liu, Qian Shen, Hong Xu
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
BackgroundAngiopoietin-like 3 (ANGPTL3) is a secretory glycoprotein. It has been demonstrated that ANGPTL3 level was upregulated in minimal change nephrotic syndrome (MCNS) kidney tissues. Subsequently, our group found that ANGPTL3 level was closely
Externí odkaz:
https://doaj.org/article/7e3f79ec52434697a50cf76e0d0fe826
Autor:
Qianqian Ma, Xiaozhi Hu, Fangyu Liu, Zhonglian Cao, Lei Han, Kaicheng Zhou, Yu Bai, Yuting Zhang, Yanyang Nan, Qianying Lv, Jia Rao, Tao Wu, Xue Yang, Haidong He, Dianwen Ju, Hong Xu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionThe pathogenic mechanisms of diabetic nephropathy (DN) include podocyte injury, inflammatory responses and metabolic disorders. Although the antagonism of Angiopoietin-like protein 3 (ANGPTL3) can alleviate proteinuria symptoms by inhibit
Externí odkaz:
https://doaj.org/article/dc4ec572366c4fbc94adf57513915ffe
Autor:
Gan Sun, Maolan Wu, Qianying Lv, Xi Yang, Junfeng Wu, Wenjing Tang, Rongxin Dai, Lina Zhou, Yuan Ding, Zhiyong Zhang, Yunfei An, Xuemei Tang, Xiangrong Zheng, Zhaoxia Wang, Li Sun, Yongmei Xie, Xiaodong Zhao, Hongqiang Du
Publikováno v:
Journal of Clinical Immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53ff634ac3673424b0fcebd04c3c3e5a
https://doi.org/10.1007/s10875-023-01453-3
https://doi.org/10.1007/s10875-023-01453-3
Autor:
Yinv Gong, Haimei Liu, Guomin Li, Tao Zhang, Yifan Li, Wanzhen Guan, Qiaoqian Zeng, Qianying Lv, Xiaomei Zhang, Wen Yao, Yu Shi, Hong Xu, Li Sun
Objectives To characterize clinical features and outcome of childhood-onset primary Sjögren’s syndrome (pSS). Methods Patients less than 18 years-old, fulfilling the 2002 the American-European Consensus Group (ACEG) criteria or 2016 the American C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab447fa056bf0c5f4c628e9b2148f53b
https://doi.org/10.21203/rs.3.rs-1940626/v1
https://doi.org/10.21203/rs.3.rs-1940626/v1
Autor:
Li Sun, Qian Shen, Yinv Gong, Yifan Li, Qianying Lv, Haimei Liu, Fei Zhao, Haiguo Yu, Lingzhi Qiu, Xiaozhong Li, Xiaoliang He, Yuqing Chen, Zhiquan Xu, Hong Xu
Publikováno v:
Lupus. 31(8)
Objective To observe the efficacy and safety of telitacicept in refractory childhood-onset systemic lupus erythematosus (cSLE). Methods A self-controlled before–after trial. Children with active SLE, aged 5–18 years, who cannot tolerate side effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902540b88daabade6964c79b8e0b1fdf
https://pubmed.ncbi.nlm.nih.gov/35499216
https://pubmed.ncbi.nlm.nih.gov/35499216